PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 174 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,611,000 | -48.4% | 209,624 | -33.5% | 0.32% | -51.9% |
| Q2 2018 | $18,634,000 | -13.1% | 315,024 | -0.0% | 0.68% | -19.7% |
| Q1 2018 | $21,445,000 | -32.3% | 315,135 | -1.6% | 0.84% | -33.2% |
| Q4 2017 | $31,666,000 | -9.2% | 320,343 | +10.0% | 1.26% | -13.4% |
| Q3 2017 | $34,865,000 | +60.8% | 291,146 | +17.4% | 1.45% | +53.8% |
| Q2 2017 | $21,679,000 | +123.4% | 248,038 | -4.9% | 0.94% | +112.8% |
| Q1 2017 | $9,702,000 | +84.7% | 260,817 | +890.9% | 0.44% | +3.3% |
| Q1 2015 | $5,253,000 | -36.2% | 26,322 | -39.5% | 0.43% | -39.9% |
| Q4 2014 | $8,239,000 | +43.9% | 43,533 | +81.4% | 0.72% | +30.2% |
| Q3 2014 | $5,726,000 | – | 24,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |